Morgan Stanley’s Aethlon Medical AEMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.48K | Hold |
409
| – | – | ﹤0.01% | 7165 |
|
|
2025
Q4 | $5.67K | Buy |
+409
| New | +$9.51K | ﹤0.01% | 7037 |
|
|
2025
Q3 | – | Sell |
-6
| Closed | -$346 | – | 8112 |
|
|
2025
Q2 | $384 | Buy |
+6
| New | +$805 | ﹤0.01% | 7487 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7850 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7503 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7628 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7537 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7338 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7303 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7385 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7416 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7471 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7621 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7682 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7776 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7943 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7956 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7747 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7582 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7476 |
|
|
2020
Q4 | – | Sell |
-17
| Closed | -$114K | – | 7028 |
|
|
2020
Q3 | $90K | Hold |
17
| – | – | ﹤0.01% | 5471 |
|
|
2020
Q2 | $138K | Hold |
17
| – | – | ﹤0.01% | 5244 |
|
|
2020
Q1 | $106K | Buy |
+17
| New | +$144K | ﹤0.01% | 5160 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6549 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6528 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6512 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6348 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6232 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6471 |
|
|
2017
Q3 | – | Hold |
0
| – | -$1K | – | 6522 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6493 |
|
|
2017
Q1 | – | Hold |
0
| – | -$1K | – | 6565 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6420 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6408 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6409 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6555 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6650 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6527 |
|
Other funds holding AEMD
IC
SC
XT
TRCT
CIAM
Morgan Stanley's AEMD Position: Q1 2026 in Review
Morgan Stanley held its Aethlon Medical (AEMD) position steady in Q1 2026 at 409 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #7165.
Morgan Stanley first reported a position in AEMD in Q1 2020 and has held it in 6 quarters since. The position peaked at $138K in Q2 2020. 11 funds tracked by Wall St. Rank hold AEMD as of Q1 2026.
- Morgan Stanley held 409 shares of Aethlon Medical worth $4.48K as of Q1 2026.
- Morgan Stanley left its Aethlon Medical share count unchanged in Q1 2026.
- Aethlon Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7165 holding.
- Morgan Stanley first reported a position in Aethlon Medical in Q1 2020 and has held it in 6 quarters since.
- Morgan Stanley's Aethlon Medical position peaked at $138K in Q2 2020.
- 11 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.